Point-of-Care Testing Market

Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.

Point-of-Care Testing Market contains market size and forecasts of Point-of-Care Testing (POCT) in global, including the following market information:

Global Point-of-Care Testing (POCT) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Point-of-Care Testing (POCT) Market Sales, 2017-2022, 2023-2028, (M Units)

Global top five Point-of-Care Testing (POCT) companies in 2021 (%)

The global Point-of-Care Testing (POCT) market was valued at 26410 million in 2021 and is projected to reach US$ 48270 million by 2028, at a CAGR of 9.0% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Blood Glucose Testing Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Point-of-Care Testing (POCT) include Roche, Abbott, Johnson & Johnson, Siemens Healthcare, Danaher, Ascensia, Bio-Rad Laboratories, BioMerieux and ARKRAY, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Point-of-Care Testing (POCT) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Point-of-Care Testing (POCT) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Units)

Global Point-of-Care Testing (POCT) Market Segment Percentages, by Type, 2021 (%)

Blood Glucose Testing

Infectious Diseases Testing

Cardiac Markers Testing

Coagulation Testing

Pregnancy and Fertility Testing

Blood Gas/Electrolytes Testing

Urinalysis Testing

Global Point-of-Care Testing (POCT) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Units)

Global Point-of-Care Testing (POCT) Market Segment Percentages, by Application, 2021 (%)

Clinics

Hospitals

Laboratory

Others

Global Point-of-Care Testing (POCT) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Units)

Global Point-of-Care Testing (POCT) Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Point-of-Care Testing (POCT) revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Point-of-Care Testing (POCT) revenues share in global market, 2021 (%)

Key companies Point-of-Care Testing (POCT) sales in global market, 2017-2022 (Estimated), (M Units)

Key companies Point-of-Care Testing (POCT) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Roche

Abbott

Johnson & Johnson

Siemens Healthcare

Danaher

Ascensia

Bio-Rad Laboratories

BioMerieux

ARKRAY

Nova Biomedical

Trividia Health

Quidel

Accriva

OraSure Technologies

Helena Laboratories

A. Menarini Diagnostics

Abaxis (Zoetis)

Ortho Clinical Diagnostics

Phamatech

Chembio Diagnostics

Trinity Biotech

ELITech Group

Response Biomedical

Princeton BioMeditech

Alfa Wassermann